75th Meeting of Gulf Central Committee for Drug Registration convened

Healthcare

75th Meeting of Gulf Central Committee for Drug Registration convened

H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Policy and Licensing of the Ministry of Health, inaugurated the 75th Meeting of the Gulf Central Committee for Drug Registration at the Al Bustan Rotana Hotel in Dubai in the presence of Dr. Mohammed al-Haidari, Head of Drug Central Registration Department and Executive Board, Health Ministers' Council for Cooperation Council States, Saudi Arabia.

Unify GCC's efforts in the pharmaceutical market.

Dr. Amin said that GCC's contemporary trends emphasizes in unifying efforts to supporting pharmaceutical market, encouraging regional producers to concentrate on innovative pharmaceutical market, and ensuring the culture of self-confidence in the local pharmaceutical industry within the society. The meeting was directed to initiatives and regulations that not only motivates the advancement of the local pharmaceutical market within the GCC however likewise carry out regulations and requirements to help with regional and global financial investment through a successful design embodied by the UAE.

Accelerated development in the local drug market.

H.E. Dr. Al Amiri indicated the stable increase in the variety of pharmaceutical factories as per the table below:.

Year. Industries.
2014. 14.
2015. 16.
2020. 34.

The table is a strong indicator of the UAE's growth in the regional pharmaceutical market. It also reflects its government's keenness through the Ministry of Health and Protection of Society and various health authorities in the country to support investment in the sector. The nation possesses a strong infrastructure of airports and free zones to offer outstanding logistical assistance to the Middle East and North Africa as well as has a modern legislation and regulations that motivates financial investment in this sector.

H.E. Dr. Al Amiri validated that the GCC is eager in encouraging its local industries to manufacture innovative and low-use medicines that are interred to the UAE as unregistered medicines just like exactly what the Ministry of Health has actually taken in the nation.

National drug equipment contends in Western markets.
Dr. Al Amiri likewise kept in mind the importance of the Executive Office in taking efforts to change the understanding of the Gulf society in showing confidence to the regional pharmaceutical markets. A number of the Gulf drugs regulate a global market and sold in the United States, Europe and in the Middle East, showing a high requirement of quality set by nationwide markets that has allowed them to succeed in the worldwide competition. The Executive Office demanded the adoption of 3 efforts which will be presented to the Gulf Health Council Ministers for approval and enactment of legislations and policies.

A comprehensive agenda to register items and pharmaceutical companies.

The conference talked about the registration of 6 new business and 23 brand-new equipments and the renewal of the registration of 3 companies and 15 centrally signed up products. It also asked to check out 7 Equal vital centers.

The conference presented exactly what was received from 10 business for the renewal of registration demand, in addition to exactly what was received from the business regarding the conclusion of signing up 50 equipments and the request for the extension of validity of 5 equipments and requested minor modifications in 6 products, along with to go over other businesses.